SCHEMBL5539462

SCHEMBL5539462

CC(C)C(C)(C)C(=O)NC(=O)c1cccc(N(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.49
LMNA P02545 2/20 0.49
KDM4E B2RXH2 6/20 0.48
SMN1; SMN2 Q16637 6/20 0.48
RAB9A P51151 5/20 0.48
NPC1 O15118 4/20 0.48
HSD17B10 Q99714 3/20 0.48
GFER P55789 2/20 0.48
MAPT P10636 5/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
ALOX15 P16050 1/20 0.45
KMT2A Q03164 3/20 0.44
HTT P42858 2/20 0.43
USP2 O75604 1/20 0.43
MEN1 O00255 1/20 0.43
MAPK14 Q16539 1/20 0.42
SMO Q99835 1/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14679338 0.85 POLB (0.54) POLBLMNAKDM4ESMN1; SMN2RAB9A
SCHEMBL5533967 0.81 HDAC8 (0.54) POLBLMNASMN1; SMN2RAB9ANPC1
SCHEMBL7495727 0.77 POLB (0.69) POLBLMNAKDM4ESMN1; SMN2RAB9A
SCHEMBL13753398 0.76 KDM4E (0.58) POLBLMNAKDM4ESMN1; SMN2RAB9A
SCHEMBL13701704 0.76 LMNA (0.56) POLBLMNAKDM4ESMN1; SMN2RAB9A
SCHEMBL13753411 0.74 POLB (0.54) POLBLMNAKDM4ESMN1; SMN2RAB9A
SCHEMBL6497629 0.72 POLB (0.63) POLBLMNAKDM4ESMN1; SMN2RAB9A
SCHEMBL31490713 0.72 POLB (0.59) POLBLMNAKDM4ESMN1; SMN2RAB9A
SCHEMBL15893980 0.71 KMT2A (0.50) POLBLMNAKDM4ESMN1; SMN2RAB9A
SCHEMBL16886343 0.71 KMT2A (0.50) POLBLMNAKDM4ESMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed